HK Stock Market Move | NTES-S (09999) rose more than 9% after performance announcement. Third quarter revenue reached 26.2 billion yuan, with a year-on-year increase of 29% in game revenue.
NetEase-S (09999) jumped more than 9% after its results, rising 9.62% to 131 Hong Kong dollars as of the time of writing, with trading volume of 1.02 billion Hong Kong dollars.
NTES-S (09999) opened more than 9% higher after the performance report, rising 9.62% to HK$131 at the time of writing, with a turnover of HK$1.02 billion.
On the news front, NetEase released its financial results for the third quarter of 2024, with a net revenue of 26.2 billion yuan. Among them, the net revenue of games and related value-added services was 20.9 billion yuan, while Youdao's net revenue was 1.6 billion yuan, an increase of 2.2% year-on-year. NetEase Cloud Music's net revenue was 2 billion yuan, up 1.3% year-on-year, and the net revenue of innovative and other businesses was 1.8 billion yuan. The gross profit was 16.5 billion yuan, with a net profit attributable to the company's shareholders of 6.5 billion yuan.
In the third quarter, the net revenue of games and related value-added services was 20.9 billion yuan, an increase of 4% from the previous quarter. Game revenue was 20.2 billion yuan, up 5% from the previous quarter, with a year-on-year increase of 29% and a quarter-on-quarter increase of 30% in client game revenue. Long-standing IPs such as "Westward Journey 2," "Identity V," and "Endless Trial" reached new highs, while "World of Warcraft" and "Hearthstone" returned to the Chinese market and broke records. The daily active users increased by over 50% and 150% respectively compared to before the suspension.
Related Articles

HK Stock Market Move | METIS TECHBIO-P(07666) has surged by nearly 7% and recently officially released the AiProtein platform and the antibody design intelligent body AARON.

HK Stock Market Move | LEPU BIO (02157) rose more than 6% in the afternoon, MRG006A has shown excellent clinical data for the treatment of advanced liver cancer in Phase I.

HK Stock Market Move | Innovative drug concepts mostly rise, industry business development deals continue to be in high demand, and the logic of policy support and commercial profitability realization remains unchanged.
HK Stock Market Move | METIS TECHBIO-P(07666) has surged by nearly 7% and recently officially released the AiProtein platform and the antibody design intelligent body AARON.

HK Stock Market Move | LEPU BIO (02157) rose more than 6% in the afternoon, MRG006A has shown excellent clinical data for the treatment of advanced liver cancer in Phase I.

HK Stock Market Move | Innovative drug concepts mostly rise, industry business development deals continue to be in high demand, and the logic of policy support and commercial profitability realization remains unchanged.

RECOMMEND





